AU2001256958A1 - Cross-reactive displacing antibodies from collagen-binding proteins and method of identification and use - Google Patents
Cross-reactive displacing antibodies from collagen-binding proteins and method of identification and useInfo
- Publication number
- AU2001256958A1 AU2001256958A1 AU2001256958A AU5695801A AU2001256958A1 AU 2001256958 A1 AU2001256958 A1 AU 2001256958A1 AU 2001256958 A AU2001256958 A AU 2001256958A AU 5695801 A AU5695801 A AU 5695801A AU 2001256958 A1 AU2001256958 A1 AU 2001256958A1
- Authority
- AU
- Australia
- Prior art keywords
- collagen
- reactive
- identification
- cross
- binding proteins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/085—Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56938—Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/305—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F)
- G01N2333/31—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F) from Staphylococcus (G)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18996800P | 2000-03-17 | 2000-03-17 | |
| US60189968 | 2000-03-17 | ||
| US19937000P | 2000-04-25 | 2000-04-25 | |
| US60199370 | 2000-04-25 | ||
| US22540200P | 2000-08-15 | 2000-08-15 | |
| US60225402 | 2000-08-15 | ||
| PCT/US2001/008554 WO2001070267A1 (fr) | 2000-03-17 | 2001-03-19 | Anticorps de deplacement a reaction croisee provenant des proteines de liaison du collagene et procede d'identification et d'utilisation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001256958A1 true AU2001256958A1 (en) | 2001-10-03 |
Family
ID=27392662
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001256958A Abandoned AU2001256958A1 (en) | 2000-03-17 | 2001-03-19 | Cross-reactive displacing antibodies from collagen-binding proteins and method of identification and use |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7241592B2 (fr) |
| EP (1) | EP1267930A4 (fr) |
| JP (1) | JP2003527440A (fr) |
| AU (1) | AU2001256958A1 (fr) |
| CA (1) | CA2403359A1 (fr) |
| WO (1) | WO2001070267A1 (fr) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003072607A1 (fr) * | 2002-02-21 | 2003-09-04 | Università Degli Studi Di Pavia | Anticorps monoclonaux a reaction croisee contre des proteines de liaison de collagene bacterien |
| CA2478029A1 (fr) * | 2002-03-05 | 2003-09-18 | Inhibitex, Inc. | Anticorps monoclonaux et polyclonaux reconnaissant des proteines staphylocoques a coagulase negative |
| EA018030B1 (ru) * | 2006-06-06 | 2013-05-30 | Круселл Холланд Б.В. | Связывающие молекулы человека, имеющие убивающую активность против стафилококков, и их применения |
| WO2008089476A1 (fr) * | 2007-01-19 | 2008-07-24 | Inhibitex, Inc. | Anticorps monoclonaux reconnaissant la protéine acm d'enterococcus faecium |
| JP5249326B2 (ja) | 2007-07-23 | 2013-07-31 | ワクチン リサーチ インターナショナル ピーエルシー | 不活化ブドウ球菌全細胞ワクチン |
| US9181329B2 (en) | 2007-08-31 | 2015-11-10 | The University Of Chicago | Methods and compositions related to immunizing against Staphylococcal lung diseases and conditions |
| CA2697538C (fr) | 2007-08-31 | 2019-02-12 | University Of Chicago | Procedes et compositions associees pour immuniser contre des maladies et des etats staphylococciques des poumons |
| US8758765B2 (en) | 2008-07-29 | 2014-06-24 | The University Of Chicago | Compositions and methods related to Staphylococcal bacterium proteins |
| US8465751B2 (en) | 2009-01-12 | 2013-06-18 | Novartis Ag | Cna—B domain antigens in vaccines against gram positive bacteria |
| SMT202000246T1 (it) | 2009-04-03 | 2020-07-08 | Univ Chicago | Composizioni e metodi relativi a varianti della proteina a (spa) |
| BR112013000097B1 (pt) | 2010-07-02 | 2022-02-01 | The University Of Chicago | Polipeptídeo imunogênico isolado, composição imunogênica e seu uso |
| US9176135B2 (en) | 2010-08-22 | 2015-11-03 | University Of Rochester | Method for predicting and preventing cardiovascular disease |
| US8945588B2 (en) | 2011-05-06 | 2015-02-03 | The University Of Chicago | Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides |
| US11446371B2 (en) | 2015-11-05 | 2022-09-20 | The Texas A&M University System | Targeting of ligand binding sites in ClfA |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997043314A2 (fr) * | 1996-05-16 | 1997-11-20 | The Texas A & M University System | Compositions de proteine de liaison du collagene et procedes d'utilisation |
-
2001
- 2001-03-19 WO PCT/US2001/008554 patent/WO2001070267A1/fr not_active Ceased
- 2001-03-19 US US09/810,428 patent/US7241592B2/en not_active Expired - Lifetime
- 2001-03-19 EP EP01930420A patent/EP1267930A4/fr not_active Withdrawn
- 2001-03-19 JP JP2001568463A patent/JP2003527440A/ja active Pending
- 2001-03-19 CA CA002403359A patent/CA2403359A1/fr not_active Abandoned
- 2001-03-19 AU AU2001256958A patent/AU2001256958A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2003527440A (ja) | 2003-09-16 |
| WO2001070267A1 (fr) | 2001-09-27 |
| CA2403359A1 (fr) | 2001-09-27 |
| US20070122416A1 (en) | 2007-05-31 |
| EP1267930A4 (fr) | 2005-01-19 |
| EP1267930A1 (fr) | 2003-01-02 |
| US7241592B2 (en) | 2007-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001264946A1 (en) | Bispecific immunoglobulin-like antigen binding proteins and method of production | |
| AU2001278076A1 (en) | Bstp-5 proteins and related reagents and methods of use thereof | |
| IL200608A0 (en) | Methods for the detection of 193p1e1b protein and use of compositions containing a 193p1e1b protein or an antibody binding thereto | |
| AU4141101A (en) | Nucleic acids, proteins, and antibodies | |
| WO2002030986A3 (fr) | ANTICORPS HUMANISES ANTI-LT-β-R | |
| AU5077101A (en) | Nucleic acids, proteins, and antibodies | |
| AU2001256958A1 (en) | Cross-reactive displacing antibodies from collagen-binding proteins and method of identification and use | |
| AU2001296301A8 (en) | Nucleic acids, proteins, and antibodies | |
| AU2002214333A1 (en) | Method of assaying antilaminin-1 antibody and application thereof | |
| AU2002365084A1 (en) | Method and reagent for the detection of proteins and peptides | |
| AU2002213954A1 (en) | Method for the selective modification of peptides and proteins | |
| AU3095801A (en) | Nucleic acids, proteins, and antibodies | |
| AU2001253092A1 (en) | Method for detection of truncated proteins | |
| GB0022333D0 (en) | Methods for identifying modulators of protein interactions | |
| AU2001229508A1 (en) | Nucleic acids, proteins, and antibodies | |
| AU2001236466A8 (en) | Nucleic acids, proteins, and antibodies | |
| AU2001277200A1 (en) | Bstp-cad protein and related reagents and methods of use thereof | |
| AU2002345063A1 (en) | Method for testing the presence of prion proteins in tissue and culture samples | |
| AU2002364192A8 (en) | Method of identifying novel proteins | |
| AU2002355475A1 (en) | Method for identification of protein function | |
| AU3972601A (en) | Nucleic acids, proteins, and antibodies | |
| AU5516201A (en) | Nucleic acids, proteins, and antibodies | |
| AU2001252878A8 (en) | Nucleic acids, proteins, and antibodies | |
| AU2001250768A1 (en) | Nucleic acids, proteins, and antibodies | |
| AU2001230958A1 (en) | Nucleic acids, proteins, and antibodies |